特发性肺纤维化
医学
机制(生物学)
任天堂
纤维化
间质性肺病
肺
内科学
疾病
癌症研究
寻常性间质性肺炎
作者
Gurparsad Singh Suri,Gurleen Kaur,Chandan Kumar Jha,Manish Tiwari
标识
DOI:10.1016/j.exger.2021.111473
摘要
Idiopathic pulmonary fibrosis (IPF) is a chronic lung fibrosing disease with high prevalence that has a prognosis worse than many cancers. There has been a recent influx of new observations aimed at explaining the mechanisms responsible for the initiation and progression of pulmonary fibrosis. However, despite this, the pathogenesis of the disease is largely unclear. Recent progress has been made in the characterization of specific pathologic and clinical features that have enhanced the understanding of pathologically activated molecular pathways during the onset and progression of IPF. This review highlights several of the advances that have been made and focus on the pathobiology of IPF. The work also details the different factors that are responsible for the disposition of the disease - these may be internal factors such as cellular mechanisms and genetic alterations, or they may be external factors from the environment. The changes that primarily occur in epithelial cells and fibroblasts that lead to the activation of profibrotic pathways are discussed in depth. Finally, a complete repertoire of the treatment therapies that have been used in the past as well as future medications and therapies is provided.
科研通智能强力驱动
Strongly Powered by AbleSci AI